A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors.
F E Stuurman
,
M P Lolkema
,
A D R Huitema
,
P M M B Soetekouw
,
H Rosing
,
L Rolfe
,
P Kaur
,
J H Beijnen
,
H van Tinteren
,
E E Voest
,
J H M Schellens
More about this publication
Journal of clinical pharmacology
Volume
53
Issue nr.
8
Pages
878-83
Publication date
01-08-2013
Full text links
Publisher website (DOI)
10.1002/jcph.108
Europe PubMed Central
23775853
Pubmed
23775853